Clinical Trial Update: A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Zutectra in liver transplant recipients with hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Zutectra (human hepatitis B immunoglobulin)

Snippet

Sponsor: Biotest | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED